Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of the drug hydroxychloroquine makes hospitalized patients substantially less likely to die.
The study,
published in the International Journal of Infectious Diseases, determined that hydroxychloroquine provided a "66% hazard ratio reduction," and hydroxychloroquine and azithromycin a 71 percent reduction, compared to neither treatment.
"Yet this is the same drug that the media and the Biden campaign spent weeks trying to discredit and spread fear and doubt around because President Trump dared to mention it as a potential treatment for coronavirus."
It added: "The new study from the Henry Ford Health System should be a clear message to the media and the Democrats: stop the bizarre attempts to discredit hydroxychloroquine to satisfy your own anti-Trump agenda. It may be costing lives."